Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Merger & Restructuring

Blue Star Merger & Restructuring Worth ₹40 Cr

Blue Star’s subsidiary, Blue Star E&E, signed a Business Transfer Agreement to sell its MedTech division to Cyrix Healthcare for up to ₹40 Crore.

Key figures
Value₹40.00 Cr
Source

NSE filing, NSE: BLUESTARCO. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Blue Star Ltd: key numbers

Share price
₹1,598.00
Market cap
₹32,857 Cr
Revenue (annual)
₹12,402 Cr
Net profit (annual)
₹527.7 Cr
P/E (TTM)
64.5×Sector 42.1×
Promoter holding
36.50%+0.00% QoQ
FII holding
12.29%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Blue Star Ltd

All →

Other merger & restructuring announcements

All →
19:53 IST NSE
Merger & RestructuringEmkay Global Financial Services Ltd EMKAY

Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr

Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.

Value
₹30.00 Cr
Execution
Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals